Search Results - Dapagliflozin

Discover the Latest on DAPA-CKD: Dapagliflozin in Patients with Chronic Kidney Disease

The full DAPA-CKD trial results will be presented and reviewed at the ESC Congress 2020, Sunday, August 30, 17:00 – 17:30 CET. Topic Renal failure and Cardiovascular Disease Chairpersons Rory Collins (Oxford, UK); Frank Ruschitzka (Zurich, Switzerland) Presentations: DAPA-CKD – Dapagliflozin in Patients with CKD: Hiddo Heerspink (Groningen, Netherlands) DAPA- CKD – Live Prime Discussion: Diederick E Grobbee (Utrecht, Netherlands) Q&A Session The...

Global Trials Focus

The ISN-ACT (Advancing Clinical Trials) team presents this monthly round up of randomized trials in nephrology. Trials are selected not just for impact, but also to showcase the diversity of research produced by the global nephrology community. Each trial is reviewed in context and has a risk of bias assessment. We hope to drive...

ISN Webinar: Diabetes and its cardiac outcomes in people with and without kidney disease (CV outcome trials)

REGISTRATION ISN Webinar: Diabetes and its cardiac outcomes in people with and without kidney disease (CV outcome trials) Kidney failure and cardiovascular complications are critical complications in diabetic patients. Further, kidney disease is a significant risk for cardiovascular events independently of classical risk factors, which is called cardiorenal connection.  Recent large-scale cardiovascular outcome studies such as...

Global Trials Focus

Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlight: SGLT-2 inhibition strikes again Dapagliflozin in Patients with Chronic Kidney Disease See the latest trials here. A summary of the highlighted trial is now available in French, Mandarin, and Spanish. Support equal access to nephrology research: Become an ISN Member!

Breakthrough Discoveries

In celebration of the 60th Anniversary of the ISN, the ISN Research Working Group (RWG), under the leadership of Chair, Adeera Levin, and Deputy Chair, Masaomi Nangaku, publishes a monthly series, “Breakthrough Discoveries”. This series highlights 60 + 1 historical discoveries of significant impact to the nephrology community. So that the selection of discoveries was...